Evidence map›Paper›PMID 39853963›Full record

ArticleJournal of diabetes investigation2025

Epidemiological characteristics and risk factors for heart failure in Japanese patients with type 2 diabetes: A retrospective analysis of the J-DREAMS database.

Mitsuru Ohsugi, Daisuke Nitta, Yusuke Naito, Kohjiro Ueki

Erratum issuedAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Mitsuru OhsugiDepartment of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-3222-8507
Daisuke NittaMedicine Division, Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan.ORCID https://orcid.org/0000-0001-5881-1533
Yusuke NaitoMedicine Division, Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan.ORCID https://orcid.org/0000-0001-8033-6708
Kohjiro UekiDepartment of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-1523-8102

Funding

Japan Agency for Medical Research and Development 15ek0210019Japan Agency for Medical Research and Development 16ek0210019Japan Agency for Medical Research and Development 20ek0210134Japan Agency for Medical Research and Development 21ek0210134Japan Agency for Medical Research and Development 22ek0210134Ministry of Health, Labour and Welfare 19FA1003Ministry of Health, Labour and Welfare 21CA2015Ministry of Health, Labour and Welfare 22FA1014Nippon Boehringer Ingelheim & Eli Lilly Diabetes Alliance
6 · The paper itself

Abstract

aimTo determine the epidemiological characteristics and risk factors for heart failure (HF) among Japanese patients with type 2 diabetes.

methodsA retrospective cohort analysis, using J-DREAMS database, was conducted from December 2015 to January 2020 with type 2 diabetes. The primary objectives were to describe patient characteristics stratified by HF history at baseline and new HF events during follow-up. The secondary objectives were to clarify the association between HF history or new HF events and clinical characteristics. The association between renal disease stage and HF was also studied.

resultsAmong 18,250 adult patients with type 2 diabetes, 3,613 (19.8%) patients had HF history and the mean age was 68.46 years, predominantly male (66.4%) with 13.32 years of mean duration of type 2 diabetes. Patients with HF history had a higher proportion of patients with nephropathy (51.2%) and coronary heart disease (55.6%) than those without HF history. Coronary heart disease (CHD) and deteriorating renal function were strongly associated with both HF history (CHD adjusted odds ratio [OR]: 7.41, 95% confidence interval [CI]: 6.05-9.08; eGFR G5 stage adjusted OR: 6.56, 95% CI: 2.97-14.49) and new HF events (CHD adjusted OR: 1.63, 95% CI: 1.17-2.29; eGFR G4 stage adjusted OR: 3.42, 95% CI: 1.81-6.47).

conclusionsComorbidities, especially CHD and deteriorating renal function, were strongly associated with HF history and new HF events among Japanese patients with type 2 diabetes. The study results suggested the importance of early intervention to treat comorbidities and maintain renal function.

Indexed as

Diabetes Mellitus, Type 2Heart FailureAgedDatabases, FactualEast Asian PeopleFemaleFollow-Up StudiesHumansJapanMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsHeart failureRisk factorsType 2 diabetes

Identifiers

PMID39853963
PMCPMC11871386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.